# Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations

> **NCT00381628** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 59 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **PROCEDURE:** epithelial cells and blood lymphocyte extraction

## Key facts

- **NCT ID:** NCT00381628
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00381628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00381628, "Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00381628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*